Sen. Bernie Sanders moves toward another hearing with pharma CEOs
Pharma execs may have to explain why they're suing Medicare over price negotiations when they sell to other governments that negotiate prices.
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your inbox on Tuesdays and Thursdays.
On the hot seat, feeling the Bern
Drug executives will soon have the chance to tell Congress why they’re suing Medicare over price negotiations when their companies sell drugs to all the other governments that negotiate prices, my colleague John Wilkerson reports.
What's Your Reaction?
